Votes: TN SB2099 | 2017-2018 | 110th General Assembly
Bill Title: As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.
Spectrum: Moderate Partisan Bill (Republican 5-1)
Status: (Passed) 2018-04-17 - Comp. became Pub. Ch. 674 [SB2099 Detail]
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Moderate Partisan Bill (Republican 5-1)
Status: (Passed) 2018-04-17 - Comp. became Pub. Ch. 674 [SB2099 Detail]
Text: Latest bill text (Chaptered) [PDF]
Voting Records
| Chamber | Vote | Date | Yea | Nay | NV | Abs | Total | Result | Source | View |
|---|---|---|---|---|---|---|---|---|---|---|
| Senate | SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 8, Nays 0 PNV 0 | 2018-03-07 | 8 | 0 | 0 | 0 | 8 | Passed | Link | View |
